| Literature DB >> 12533294 |
Daniel H Rice1, Dale D Hancock, Paivi M Roozen, Maryanne H Szymanski, Beth C Scheenstra, Kirsten M Cady, Thomas E Besser, Paul A Chudek.
Abstract
Household contamination with Salmonella enterica increases when occupational exposure exists (cattle farms with known salmonellosis in cattle, a salmonella research laboratory, or a veterinary clinic experiencing an outbreak of salmonellosis). Fifteen of 55 (27.2%) vacuum cleaner bags from households with occupational exposure to S. enterica were positive versus 1 of 24 (4.2%) without known exposure. Use of a carpet cleaner and several cleaners/disinfectants reduced, but failed to eliminate, S. enterica from artificially contaminated carpet.Entities:
Mesh:
Year: 2003 PMID: 12533294 PMCID: PMC2873743 DOI: 10.3201/eid0901.020214
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Salmonella enterica culture results from the contents of household vacuum cleaner bags collected from homes with five different exposure categories
| Exposure category | No. positive (%) | No. cultured | Serotypes isolated |
|---|---|---|---|
| No contact with livestock or animal salmonellosis | 0 (0) | 12 |
|
| Contact with livestock, no known salmonellosis | 1 (8.3) | 12 | Dublin |
| Contact with livestock with salmonellosis | 8 (30.8) | 26 | Typhimurium |
| Contact with veterinary clinic with many cases of cat salmonellosis | 3 (18.8) | 16 | Typhimurium |
| Employment in laboratory engaged in research on | 4 (30.8) | 13 | Typhimurium |
| Total | 16 (20.3) | 79 |
Log10 CFU/mL Salmonella enterica (standard error) on contaminated carpet segments cleaned with a commercial carpet cleaner followed by different sanitizers
|
|
| Cleaned by a commercial carpet cleaner followed by | ||||
|---|---|---|---|---|---|---|
| Control | No sanitizer | Chlorhexidinea | Phenolic disinfectantb | Quaternary ammoniumc | ||
| No. carpet segments/treatment | 1 | 2 | 2 | 2 | 2 | |
| Pretreatment | 2.87 | 3.36 (0.18) | 2.44 (0.16) | 3.18 (0.02) | 3.28 (0.11) | |
| Posttreatment | 2.60 | 2.26 (0.09) | 2.54 (0.36) | 0.81 (0.81) | 1.67 (0.27) | |
| Mean change | -0.27 | -1.10 (0.27) | 0.10 (0.52) | -2.37 (0.79) | -1.61 (0.38) | |
aVirosan Bio-Ceutic, Boehringer Ingelheim Vetmedica., St Joseph, MO. bLpH Ag, STERIS Corp., St. Louis, MO. cLysol, Reckitt Benckiser Inc., Wayne, NJ. 1 This study was performed at the Field Disease Investigation Unit, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164-7060, USA.